Kendra M. Haney

发表

Comparative Docking Study of Anibamine as the First Natural Product CCR5 Antagonist in CCR5 Homology Models

Yan Zhang, Guo Li, Kendra M. Haney, 2009, J. Chem. Inf. Model..

Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.

Kendra M. Haney, D. Selley, Derong Ding, 2012, Organic & biomolecular chemistry.

The natural product CCR5 antagonist anibamine and its analogs as anti-prostate cancer agents.

Kendra M. Haney, F. Zhang, D. Gewirtz, 2011, Bioorganic & medicinal chemistry letters.

Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents.

Kendra M. Haney, Z. Zehner, D. Gewirtz, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and Evaluation of Anibamine and Its Analogs as Novel Anti-Prostate Cancer Agents

Kendra M. Haney, 2009 .

Comparative Docking Study of Anibamine as the First Natural Product CCR5 Antagonist in CCR5 Homology Models

Kendra M. Haney, Yan Zhang, G. Kellogg, 2009, J. Chem. Inf. Model..

The potential role of anibamine, a natural product CCR5 antagonist, and its analogues as leads toward development of anti-ovarian cancer agents.

Kendra M. Haney, X. Fang, Yan Zhang, 2012, Bioorganic & medicinal chemistry letters.

Structure activity relationship studies of natural product chemokine receptor CCR5 antagonist anibamine toward the development of novel anti prostate cancer agents.

Kendra M. Haney, J. Ware, Yan Zhang, 2012, European journal of medicinal chemistry.

Regio- and stereoselective syntheses of the natural product CCR5 antagonist anibamine and its three olefin isomers.

Kendra M. Haney, G. Kellogg, Saheem A. Zaidi, 2011, The Journal of organic chemistry.

Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents.

Kendra M. Haney, Zhuo Zhang, Yan Zhang, 2014, Bioorganic & medicinal chemistry letters.